Already a member? Sign in
Escitalopram is an antidepressant in a group of drugs called selective serotonin reuptake inhibitors (SSRIs). It is used to treat anxiety and major depressive disorder. Off label it is used for mild agitation in patients with dementia.
| Purpose | # of patients |
# of patients with evaluations
Efficacy
|
Major | Moderate | Slight | None | Can’t tell |
|---|---|---|---|---|---|---|---|
| Depressed mood | 874 | 282 |
|
|
|
|
|
| Anxious mood | 341 | 113 |
|
|
|
|
|
| Major Depressive Disorder | 288 | 44 |
|
|
|
|
|
| Treat my mood condition(s) | 257 | 73 |
|
|
|
|
|
| Dysthymia | 62 | 10 |
|
|
|
||
| Other | 51 | 9 |
|
|
|
|
|
See all 1493 patients currently taking Escitalopram
Mouse over the table for more information
Commonly reported side effects, conditions, and hospitalizations associated with Escitalopram
| Sex drive (libido) decreased | 77 | |
|---|---|---|
| Weight gain | 51 | |
| Fatigue | 42 | |
| Apathy | 38 | |
| Brain fog | 29 | |
| Insomnia | 27 | |
| See all 134 reported side effects ▼ | ||
Frequently reported dosages based on patients currently taking Escitalopram. See all 34 dosages ►
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Did not seem to work | 237 | ||
| Doctor's advice | 164 | ||
| Side effects too severe | 159 | ||
| Other | 124 | ||
| Expense | 88 | ||
| Course of treatment ended | 44 | ||
| Personal research | 34 | ||
| Change in health plan coverage | 24 | ||
| Not indicated | 7 |
Adherence
Taking treatment as prescribed
Adherence of Escitalopram
Always |
421 | 80% |
|
|---|---|---|---|
Usually |
85 | 16% |
|
Sometimes |
8 | 2% |
|
Never |
14 | 3% |
|
Burden
Difficulty being on treatment
Burden of Escitalopram
Very |
16 | 3% |
|
|---|---|---|---|
Somewhat |
36 | 7% |
|
A little |
87 | 16% |
|
Not at all |
389 | 74% |
|
Cost
Paid out of pocket
Cost of Escitalopram
$200+ |
5 | 1% |
|
|---|---|---|---|
$100-199 |
17 | 5% |
|
$50-99 |
50 | 14% |
|
$25-49 |
117 | 33% |
|
< $25 |
164 | 46% |
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on February 11, 2012.